Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 2 of 2

Full-Text Articles in Medicine and Health Sciences

The Analysis Of Diruthenium Compounds On Human Cells As Potential Chemotherapeutic Agents, Elizabeth Mcculloch Jan 2015

The Analysis Of Diruthenium Compounds On Human Cells As Potential Chemotherapeutic Agents, Elizabeth Mcculloch

Honors Program Theses

Chemotherapy is a common method of cancer treatment, and cisplatin is a common anticancer compound used in chemotherapy. While effective, cisplatin is known to cause many side effects, and people can form resistance to it. Because of these problems, new chemotherapeutic compounds are needed. One compound that has shown anticancer properties, an ability to overcome resistance, and nontoxicity is ruthenium. Multiple mono-ruthenium compounds have been previously studied and were found to be effective. The current research project synthesized a diruthenium compound Cp2Ru2(bipy)2(DMSO)2 and exposed the compound to human liver cells (HepG2) to determine …


Analysis Of Protein Expression For Potential Biomarkers In Human Pancreatic Tumor Cell Lines, Jade Ashley Simpson Jan 2015

Analysis Of Protein Expression For Potential Biomarkers In Human Pancreatic Tumor Cell Lines, Jade Ashley Simpson

Honors Program Theses

Pancreatic cancer is an aggressive cancer of the pancreas that has been shown to have extremely low survival rates. It can be quite lethal because of its asymptomatic early stages and inability to detect cancer at the cellular level. Once diagnosed, the cancer will have usually spread or metastasized beyond surgical resection. Thus, research is focused on finding potential biomarkers in tumor cell lines to help in earlier diagnosis of this disease leading to better treatment options. Previous work using bioinformatics data suggest several cellular genes including, CTHCR1, EPPK1, AHNAK2, and IGHG3, can be potential biomarkers for pancreatic cancer. The …